SCHEMBL6234077

SCHEMBL6234077

Cc1ccc(Nc2nc3ccccc3nc2-c2cccs2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.50
PDE5A O76074 1/20 0.49
ALDH1A1 P00352 7/20 0.47
KDM4E B2RXH2 6/20 0.47
MAPT P10636 6/20 0.47
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
LMNA P02545 4/20 0.47
KDM1A O60341 2/20 0.47
HTT P42858 2/20 0.47
GBA1 P04062 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
RPS6KB2 Q9UBS0 2/20 0.45
HPGD P15428 2/20 0.45
NPY5R Q15761 1/20 0.45
RAB9A P51151 3/20 0.44
POLB P06746 2/20 0.44
NPC1 O15118 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6259663 0.88 PDE5A (0.61) GAAPDE5AALDH1A1KDM4EMAPT
SCHEMBL6238376 0.86 PDE5A (0.49) GAAPDE5AALDH1A1KDM4EMAPT
SCHEMBL6237808 0.86 KMT2A (0.49) GAAPDE5AALDH1A1KDM4EMAPT
SCHEMBL6239210 0.80 MAPT (0.47) PDE5AALDH1A1KDM4EMAPTMEN1
SCHEMBL7690215 0.77 RPS6KB2 (0.60) GAAPDE5AALDH1A1KDM4EMAPT
SCHEMBL7695652 0.77 RPS6KB2 (0.60) PDE5AALDH1A1KDM4EMAPTMEN1
SCHEMBL6236522 0.77 ABCG2 (0.48) PDE5AALDH1A1KDM4EMAPTMEN1
SCHEMBL6237490 0.77 ABCG2 (0.67) PDE5AALDH1A1KDM4EMAPTMEN1
SCHEMBL6235369 0.77 MEN1 (0.58) GAAPDE5AALDH1A1KDM4EMAPT
SCHEMBL7696931 0.76 RPS6KB2 (0.55) GAAALDH1A1KDM4EMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005007099-A2 PKB INHIBITORS AS ANTI-TUMOR AGENTS IMCLONE SYSTEMS INCORPORATED (US) 2005-01-27 WO disclosed